Modulatory role of ketogenic diet on neuroinflammation; a possible drug naïve strategy to treatment of Parkinson’s disease

Sheyda Shaafi, Javad Mahmoudi, Safa Najmi, Saeed Sadigh-Eteghad, Mehdi Farhoudi, Hamed Aliasgharpour

Abstract


Parkinson’s disease is the second common neurological disease associated with elderly. Neuroinflammation contributes in neuronal death in Parkinson’s disease (PD). The ketogenic diet (KD) is low in carbohydrates, adequate in protein, and high in fat, has been used in intractable epilepsy and seems to be effective in neurologic disorders. The implication of Neuroinflammation in PD has been emphasized and there is evidence show that KD may provide advantages to reduce neuroinflammatory adverse effects. Based on this surmise, it seems that KD could reverse some neuronal injuries of PD.

 

Keywords: Ketogenic diet, Neuroinflammation, Parkinson’s disease


Full Text:

PDF

References


Mahmoudi J, Mohajjel Nayebi A, Reyhani-Rad S, Samini M. Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats. Advanced pharmaceutical bulletin 2012;2(2):149-55.

Mahmoudi J, Nayebi AM, Samini M, Reyhani-Rad S, Babapour V. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. Pharmacological reports : PR 2011;63(4):908-14.

Sharifi H, Nayebi AM, Farajnia S, Haddadi R. Effect of Chronic Administration of Buspirone and Fluoxetine on Inflammatory Cytokines in 6-Hydroxydopamine-lesioned Rats. Drug research 2014.

Winklhofer KF, Haass C. Mitochondrial dysfunction in Parkinson's disease. Biochimica et biophysica acta 2010;1802(1):29-44.

Shaafi S, Mahmoudi J, Pashapour A, Farhoudi M, Sadigh-Eteghad S, Akbari H. Ketogenic Diet Provides Neuroprotective Effects against Ischemic Stroke Neuronal Damages. 2014.

Streijger F, Plunet WT, Lee JH, Liu J, Lam CK, Park S, et al. Ketogenic diet improves forelimb motor function after spinal cord injury in rodents. PloS one 2013;8(11):e78765.

Vizuete AF, De Souza DF, Guerra MC, Batassini C, Dutra MF, Bernardi C, et al. Brain changes in BDNF and S100B induced by ketogenic diets in Wistar rats. Life sciences 2013;92(17):923-8.

Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(1):1-16.

Roy M, Nugent S, Tremblay-Mercier J, Tremblay S, Courchesne-Loyer A, Beaudoin JF, et al. The ketogenic diet increases brain glucose and ketone uptake in aged rats: a dual tracer PET and volumetric MRI study. Brain research 2012;1488:14-23.

Yao J, Chen S, Mao Z, Cadenas E, Brinton RD. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PloS one 2011;6(7):e21788.

Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural pharmacology 2006;17(5-6):431-9.

Van Der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutrition & Metabolism 2005;2:28-.

Zhao Z, Lange DJ, Voustianiouk A, Macgrogan D, Ho L, Suh J, et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC neuroscience 2006;7(1):29.

Hirsch EC, Vyas S, Hunot S. Neuroinflammation in Parkinson's disease. Parkinsonism & related disorders 2012;18 Suppl 1:S210-2.

Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Annals of neurology 2003;53 Suppl 3:S49-58; discussion S-60.

Sharifi H, Mohajjel Nayebi A, Farajnia S. 8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats. Iranian Journal of Basic Medical Sciences 2013;16(12):1270-5.

Meredith GE, Sonsalla PK, Chesselet M-F. Animal models of Parkinson’s disease progression. Acta neuropathologica 2008;115(4):385-98.

Khorrami A, Ghanbarzadeh S, Mahmoudi J, Nayebi AM, Maleki-Dizaji N, Garjani A. Investigation of the Memory Impairment in Rats Fed with Oxidized-Cholesterol-Rich Diet Employing Passive Avoidance Test. Drug research 2014.

Yang X, Cheng B. Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. Journal of molecular neuroscience : MN 2010;42(2):145-53.

Cheng B, Lu H, Bai B, Chen J. d-β-Hydroxybutyrate inhibited the apoptosis of PC12 cells induced by H2O2 via inhibiting oxidative stress. Neurochemistry International 2013;62(5):620-5.

Floyd RA. Antioxidants, Oxidative Stress, and Degenerative Neurological Disorders. Proceedings of the Society for Experimental Biology and Medicine 1999;222(3):236-45.

Westerink RHS, Ewing AG. The PC12 cell as model for neurosecretion. Acta physiologica (Oxford, England) 2008;192(2):273-85.

Sadigh-Eteghad S, Talebi M, Farhoudi M, Mahmoudi J, Reyhani B. Effects of Levodopa loaded chitosan nanoparticles on cell viability and caspase-3 expression in PC12 neural like cells. Neurosciences 2013;18(3): 281-3.


Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

2013-2019 (CC-BY) Australian International Academic Centre PTY.LTD.

Advances in Bioscience and Clinical Medicine